WMJ Vol 123 Issue 5: Improving HPV Vaccination Rates: A Comprehensive Evaluation of a Provider-Centered Educational Initiative in a Wisconsin Health Care System
ABSTRACT
Introduction: Human papillomavirus (HPV) infection poses significant public health concerns due to its prevalence and association with various cancers. This study assesses a 2014 quality improvement initiative in Wisconsin's largest health care system. The intervention aimed to improve HPV vaccine initiation and completion among eligible patients and to reduce the gap in vaccination rates between males and females.
Methods: Educational sessions delivered to health care providers and staff at select clinics focused on current HPV vaccination recommendations and strategies for patient communication. Preintervention and postintervention surveys assessed changes in clinician knowledge and attitudes. Clinic-level data on HPV vaccination rates compared intervention and control clinics at 12 and 36 months following the intervention.
Results: Postintervention knowledge and attitudes regarding HPV vaccination improved, and intervention clinics demonstrated notable increases in HPV vaccine initiation and completion rates across various age and sex groups at 12- and 36-month follow-up. The gap between female and male HPV vaccination rates narrowed in some age groups in intervention clinics, but the effect was inconsistent.
Conclusions: This study highlights the potential effectiveness of an in-person educational intervention in improving HPV vaccination rates in a health care system. Clinicians' enhanced understanding of vaccination guidelines, coupled with real-time data feedback, contributed to sustained improvements. To address resource challenges, future interventions may explore cost-effective alternatives. These findings underscore the pivotal role of clinicians in increasing HPV vaccine uptake, emphasizing the importance of aligning interventions with evolving vaccination recommendations to combat HPV-related cancers more effectively.
Intended Audience
The intended audience for this continuing education activity is healthcare professionals caring for the people of Wisconsin and beyond.
Learning Objectives
As a result of participating in this journal-based activity, healthcare team members will be able to:
- Discuss the importance of HPV vaccination and current Centers for Disease Control and Prevention (CDC) recommendations
- Describe the impact of a reported educational intervention on knowledge, attitudes, and practices of clinicians and HPV vaccine initiation and completion rates
- Discuss applicability of the study findings to the educational needs and team-based practice related to HPV vaccination in the learner's healthcare setting
FACULTY DISCLOSURE
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.
For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.
| Name of Individual | Individual's Role in Activity | Financial Relationship Disclosure | Discussion of Unlabeled/Unapproved Uses of Drugs/Devices |
| Marianna Shershneva, MD, PhD | Accreditation Specialist | No relevant relationships with ineligible companies to disclose | No |
| James Eberhard, MFA | Accreditation Specialist | No relevant relationships with ineligible companies to disclose | No |
| Malia Jones, PhD, MPH | Author | No relevant relationships with ineligible companies to disclose | No |
| James H Conway, MD | Author | No relevant relationships with ineligible companies to disclose | No |
| Lindsay Geier, MD | Author | No relevant relationships with ineligible companies to disclose | No |
| Sarah Bradley, MD | Author | No relevant relationships with ineligible companies to disclose | No |
| Jeff Pier, BA | Author | No relevant relationships with ineligible companies to disclose | No |
| Nicholas B Schmuhl | Author | No relevant relationships with ineligible companies to disclose | No |
| Andrew E. Petroll, MD, MS | Reviewer | No relevant relationships with ineligible companies to disclose | No |
| Mansoor Mirza, MD, FACP | Reviewer | No relevant relationships with ineligible companies to disclose | No |
| Fahad Aziz, MD | Editor | No relevant relationships with ineligible companies to disclose | No |
| Jennifer Esch, PharmD, MBA, BCPS | Reviewer | No relevant relationships with ineligible companies to disclose | No |
| Sue Wenker, PT, PhD, MS, FNAP | Reviewer | No relevant relationships with ineligible companies to disclose | No |
| Roberta Pawlak, PhD, RN, NEABC | Reviewer | No relevant relationships with ineligible companies to disclose | No |
*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on, patients. The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.
Accreditation Statements
| Accreditation Logos | Accreditation Statements |
![]() | In support of improving patient care, this activity has been planned and implemented by the University of Wisconsin–Madison ICEP and the Wisconsin Medical Journal. The University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. |
Credit Designation Statements | |
American Medical Association (AMA) The University of Wisconsin–Madison ICEP designates this journal-based CE activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. | |
![]() | American Academy of Physician Assistants (AAPA) The University of Wisconsin–Madison ICEP has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until 12/02/2025. PAs should only claim credit commensurate with the extent of their participation. |
American Nurses Credentialing Center (ANCC) The University of Wisconsin–Madison ICEP designates this journal-based CE activity for a maximum of 1.0 ANCC contact hour. | |
Accreditation Council for Pharmacy Education (ACPE) The University of Wisconsin–Madison ICEP designates this knowledge-based activity for 1.0 hours or 0.1 CEUs. Credit can be earned by successfully completing the activity. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion. | |
Continuing Education Units The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 continuing education units (CEUs) or 1 hour. | |
Available Credit
- 1.00 AAPA Category 1 CME
- 1.00 ACPE Contact Hours - Pharmacist
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 University of Wisconsin–Madison Continuing Education Hours
- 1.00 Approved for AMA PRA Category 1 Credit™
Accessibility
If you need anything to participate in this program, please contact [email protected].
Required Hardware/software
Free, current version of Chrome, Firefox, Safari, or Edge. Some older browsers and Microsoft Internet Explorer could produce error messages or not display the content correctly.
Free, current version of Adobe Acrobat Reader or other .pdf reader.

Facebook
X
LinkedIn
Forward
